Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. US Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Clinical Trials

Content :

Clinical Trials

At the start of any new drug or vaccine lies an understanding of a disease, the identification of a target (therapeutic or vaccine) and a selection of the most active substances to provide treatment, relief or prevention. It takes two to four years of work to prepare a candidate drug or vaccine for development.

 

What is a clinical trial?

 

A clinical trial (also called clinical study) is designed to verify the efficacy and safety of a compound for use by human beings. It takes place after in vitro and animal studies (preclinical testing) have proved satisfactory.

The compound, also called investigational product, is compared either to a placebo (a substance with no pharmacological activity) or to existing treatments, to determine whether it is more or less effective.

The clinical trial determines the effective dose regimen, possible toxicity and the nature and frequency of adverse events it may cause.

 

Why are clinical trials necessary?

 

Clinical trials are a mandatory part of the procedure leading to approval of a drug for marketing. Before new treatments can be made available to all potential patients, they must be deemed effective and well tolerated. Clinical trials are used to validate new treatments but also to define the patient categories for which they are most effective. Finally, clinical trials help to gain a better understanding of the characteristics of a disease. Clinical trials are a mandatory part of the procedure leading to approval of a drug for marketing.

 

What are the criteria for the decision to launch a clinical study?

 

After identification of a compound under research, it is evaluated in vitro and then on animals. These steps provide a preliminary assessment of tolerance and therapeutic value. If all the data is satisfactory, the next step is to consider tests involving human beings.

The pharmaceutical manufacturer then submits a request to an Independent Ethics Committee (IEC) or Institutional Review Board (IRB), a completely independent body whose mission is to scrutinize the test procedures and protocol. The committee’s decision is based in particular on the pertinence of the project and the protection afforded to participants. The clinical trial may proceed only once it has been approved by the committee, which also follows regularly the progress of the trial to ensure continuity in the safety and welfare of the participants.

 

To find out more information about clinical trials sponsored by Sanofi US, please use the links provided below to publicly accessible websites in the U.S.

 

 

Last update: March 11, 2016